These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30210591)
1. Hypermethylation of the κ1 opioid receptor promoter in Chinese heroin and methamphetamine addicts. Ji H; Liu G; Xu X; Liu H; Xu L; Hu H; Chen Y; Hong Q; Wang Q; Shen W; Li L; Xie X; Zhou W; Duan S Exp Ther Med; 2018 Sep; 16(3):2392-2398. PubMed ID: 30210591 [TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor D4 promoter hypermethylation increases the risk of drug addiction. Ji H; Xu X; Liu G; Liu H; Wang Q; Shen W; Li L; Xie X; Hu H; Xu L; Zhou W; Duan S Exp Ther Med; 2018 Feb; 15(2):2128-2133. PubMed ID: 29434815 [TBL] [Abstract][Full Text] [Related]
3. A significant association between BDNF promoter methylation and the risk of drug addiction. Xu X; Ji H; Liu G; Wang Q; Liu H; Shen W; Li L; Xie X; Zhou W; Duan S Gene; 2016 Jun; 584(1):54-59. PubMed ID: 26976342 [TBL] [Abstract][Full Text] [Related]
4. OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease. Ji H; Wang Y; Liu G; Xu X; Dai D; Chen Z; Zhou D; Zhou X; Han L; Li Y; Zhuo R; Hong Q; Jiang L; Zhang X; Liu Y; Xu L; Chang L; Li J; An P; Duan S; Wang Q Neurosci Lett; 2015 Oct; 606():24-9. PubMed ID: 26300544 [TBL] [Abstract][Full Text] [Related]
5. Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populations. Liu G; Ji H; Liu J; Xu C; Chang L; Cui W; Ye C; Hu H; Chen Y; Zhou X; Duan S; Wang Q Neurosci Lett; 2017 Jan; 636():170-176. PubMed ID: 27838450 [TBL] [Abstract][Full Text] [Related]
6. Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. Nielsen DA; Hamon S; Yuferov V; Jackson C; Ho A; Ott J; Kreek MJ Hum Genet; 2010 Jun; 127(6):639-49. PubMed ID: 20237803 [TBL] [Abstract][Full Text] [Related]
7. Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. Xu C; Liu G; Ji H; Chen W; Dai D; Chen Z; Zhou D; Xu L; Hu H; Cui W; Chang L; Zha Q; Li L; Duan S; Wang Q Mol Med Rep; 2018 Nov; 18(5):4297-4302. PubMed ID: 30152845 [TBL] [Abstract][Full Text] [Related]
8. Self-perception of drug abusers and addicts and investigators' perception of etiological factors of psychoactive drug addiction. Brajević-Gizdić I; Mulić R; Pletikosa M; Kljajić Z Coll Antropol; 2009 Mar; 33(1):225-31. PubMed ID: 19408630 [TBL] [Abstract][Full Text] [Related]
9. The genetic susceptibility analysis of TAAR1 rs8192620 to methamphetamine and heroin abuse and its role in impulsivity. Tang F; Yang L; Yang W; Li C; Zhang J; Liu J Eur Arch Psychiatry Clin Neurosci; 2024 Mar; 274(2):453-459. PubMed ID: 37145176 [TBL] [Abstract][Full Text] [Related]
10. Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese. Zhang J; Fu X; Lu Y; Cheng C; Wang K; Zhu Y; Xie Q Brain Res; 2022 Oct; 1793():148050. PubMed ID: 35964682 [TBL] [Abstract][Full Text] [Related]
11. Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Teh LK; Izuddin AF; M H FH; Zakaria ZA; Salleh MZ Biol Res Nurs; 2012 Apr; 14(2):188-96. PubMed ID: 21613340 [TBL] [Abstract][Full Text] [Related]
12. Mortalities of methamphetamine, opioid, and ketamine abusers in Shanghai and Wuhan, China. Li F; Liu J; Yip PSF; Lu X; Liu S Forensic Sci Int; 2020 Jan; 306():110093. PubMed ID: 31816483 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine. Isaza C; Henao J; Beltrán L; Porras L; Gonzalez M; Cruz R; Carracedo A Colomb Med (Cali); 2013 Jan; 44(1):19-25. PubMed ID: 24892317 [TBL] [Abstract][Full Text] [Related]
14. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects. Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446 [TBL] [Abstract][Full Text] [Related]
15. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885 [TBL] [Abstract][Full Text] [Related]
16. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. Gao X; Wang Y; Lang M; Yuan L; Reece AS; Wang W OMICS; 2017 Jul; 21(7):404-412. PubMed ID: 28692418 [TBL] [Abstract][Full Text] [Related]
17. Increased serum brain-derived neurotrophic factor levels during opiate withdrawal. Zhang J; Zhang X; Su H; Tao J; Xie Y; Han B; Lu Y; Wei Y; Sun H; Wang Y; Wu W; Zou S; Liang H; Zoghbi AW; Tang W; He J Neurosci Lett; 2014 Jun; 571():61-5. PubMed ID: 24810885 [TBL] [Abstract][Full Text] [Related]
18. Elevated OPRD1 promoter methylation in Alzheimer's disease patients. Ji H; Wang Y; Liu G; Chang L; Chen Z; Zhou D; Xu X; Cui W; Hong Q; Jiang L; Li J; Zhou X; Li Y; Guo Z; Zha Q; Niu Y; Weng Q; Duan S; Wang Q PLoS One; 2017; 12(3):e0172335. PubMed ID: 28253273 [TBL] [Abstract][Full Text] [Related]
19. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Fishbein DH; Krupitsky E; Flannery BA; Langevin DJ; Bobashev G; Verbitskaya E; Augustine CB; Bolla KI; Zvartau E; Schech B; Egorova V; Bushara N; Tsoy M Drug Alcohol Depend; 2007 Sep; 90(1):25-38. PubMed ID: 17382488 [TBL] [Abstract][Full Text] [Related]
20. Methamphetamine persistently increases alpha-synuclein and suppresses gene promoter methylation within striatal neurons. Biagioni F; Ferese R; Limanaqi F; Madonna M; Lenzi P; Gambardella S; Fornai F Brain Res; 2019 Sep; 1719():157-175. PubMed ID: 31150652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]